Chinese guideline on sublingual immunotherapy for allergic rhinitis and asthma.

The present guideline on sublingual immunotherapy (SLIT) for allergic rhinitis (AR) and allergic asthma (AS) has been developed by a panel of experts on behalf of the Chinese Society of Allergy to guide the clinical practice of SLIT in China. The panel included eminent clinical physicians and scientific specialists, who majored in the fields of Otolaryngology, Respirology, Pediatrics, Allergy and Clinical Immunology, and focused their investigations on two common allergic airway diseases (namely AR and AS) in China. During the past few decades, AR and AS have shown increasing prevalence worldwide, and resulted in substantial direct and indirect costs (1).

[1]  Yaozu Zhang,et al.  Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis. , 2019, American journal of otolaryngology.

[2]  Tangchun Wu,et al.  Prevalence, risk factors, and management of asthma in China: a national cross-sectional study , 2019, The Lancet.

[3]  Z. Xia,et al.  Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study , 2019, International Archives of Allergy and Immunology.

[4]  W. Guan,et al.  Distribution and Determinants of Dermatophagoides Mites Sensitization ofAllergic Rhinitis and Allergic Asthma in China , 2019, International Archives of Allergy and Immunology.

[5]  L. Klimek,et al.  Recent developments and highlights in allergen immunotherapy , 2018, Allergy.

[6]  Luo Zhang,et al.  Increasing Prevalence of Allergic Rhinitis in China , 2018, Allergy, asthma & immunology research.

[7]  Lifeng Zhou,et al.  Role of leptin in allergic rhinitis during sublingual immunotherapy , 2018, European Archives of Oto-Rhino-Laryngology.

[8]  Miao-miao Han,et al.  Sublingual immunotherapy for treating adult patients with allergic rhinitis induced by house dust mite among Chinese Han population , 2018, Medicine.

[9]  D. Wang,et al.  The efficacy of sublingual immunotherapy for allergic diseases in Asia. , 2018, Allergology international : official journal of the Japanese Society of Allergology.

[10]  Chuling Li,et al.  Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis , 2018, The Indian Journal of Pediatrics.

[11]  X. Huang,et al.  Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma , 2018, Irish Journal of Medical Science (1971 -).

[12]  Mao Huang,et al.  Prevalence and risk factors of asthma in mainland China: The CARE study. , 2018, Respiratory medicine.

[13]  A. Sheikh,et al.  EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis , 2018, Allergy.

[14]  Jg Liu,et al.  Prevalence of pollen‐induced allergic rhinitis with high pollen exposure in grasslands of northern China , 2018, Allergy.

[15]  X. Ni,et al.  Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school-age children with allergic rhinitis. , 2018, Allergologia et immunopathologia.

[16]  H. Lin,et al.  The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis. , 2017, Allergologia et immunopathologia.

[17]  L. Han,et al.  [Evaluation of efficacy of 1 year after completing the 2-year specific sublingual immunotherapy treatment course in allergic rhinitis]. , 2017, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[18]  Zheng Liu,et al.  Chinese Guideline on allergen immunotherapy for allergic rhinitis. , 2017, Journal of thoracic disease.

[19]  D. Bernstein,et al.  A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice , 2017, Postgraduate medicine.

[20]  Yue Li,et al.  Nonadherence to sublingual immunotherapy in allergic rhinitis: a real‐life analysis , 2017, International forum of allergy & rhinology.

[21]  C-H He,et al.  Clinical evaluation of sublingual administration of dust mite drops in the treatment of allergic asthma and allergic rhinitis of children. , 2016, European review for medical and pharmacological sciences.

[22]  Peng Li,et al.  The influence of house dust mite sublingual immunotherapy on the TSLP‐OX40L signaling pathway in patients with allergic rhinitis , 2016, International forum of allergy & rhinology.

[23]  D. Saporta.  Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice , 2016, BioMed research international.

[24]  Y. J. Li,et al.  Clinical features of allergic rhinitis in children of Shanghai, China. , 2016, Genetics and molecular research : GMR.

[25]  Yuan Zhang,et al.  An increased prevalence of self‐reported allergic rhinitis in major Chinese cities from 2005 to 2011 , 2016, Allergy.

[26]  Xiaowei Qin,et al.  Decreased level of osteopontin in children with allergic rhinitis during sublingual immunotherapy. , 2016, International journal of pediatric otorhinolaryngology.

[27]  Z. Lin,et al.  The effects of house dust mite sublingual immunotherapy in patients with allergic rhinitis according to duration , 2016, International forum of allergy & rhinology.

[28]  P. Demoly,et al.  Choosing the optimal dose in sublingual immunotherapy: Rationale for the 300 index of reactivity dose , 2015, Clinical and Translational Allergy.

[29]  Geng Xu,et al.  Increased Expression of miR-146a in Children With Allergic Rhinitis After Allergen-Specific Immunotherapy , 2015, Allergy, asthma & immunology research.

[30]  Shiying Xu,et al.  [Onset time and efficacy of sublingual immunotherapy with Dermatophagoides farinae drops in children with allergic rhinitis]. , 2015, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[31]  Xiaowei Feng,et al.  [Effects of house dust mite sublingual immunotherapy in children with allergic rhinitis and asthma]. , 2015, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[32]  P. Demoly,et al.  Clinical contraindications to allergen immunotherapy: an EAACI position paper , 2015, Allergy.

[33]  Z. Xia,et al.  [Efficacy of sublingual immunotherapy with Dermatophagoides farina drops in monosensitized and polysensitized patients with allergic rhinitis]. , 2015, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[34]  Mingbang Wang,et al.  Prevalence of allergic rhinitis among elementary and middle school students in Changsha city and its impact on quality of life , 2015, The Journal of Laryngology & Otology.

[35]  V. Backer,et al.  SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[36]  Peng Li,et al.  Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases , 2014, International forum of allergy & rhinology.

[37]  M. Tian,et al.  Effects of sublingual immunotherapy for Dermatophagoides farinae on Th17 cells and CD4+CD25+ regulatory T cells in peripheral blood of children with allergic asthma , 2014, International forum of allergy & rhinology.

[38]  J. Bousquet,et al.  Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. , 2014, Allergy.

[39]  J. Bousquet,et al.  Sublingual immunotherapy: World Allergy Organization position paper 2013 update , 2014, The World Allergy Organization journal.

[40]  Lanfang Cao,et al.  Efficacy and Safety of Sublingual Immunotherapy in Children Aged 3–13 Years with Allergic Rhinitis , 2014, American journal of rhinology & allergy.

[41]  Luo Zhang,et al.  Prevalence of Allergic Rhinitis in China , 2013, Allergy, asthma & immunology research.

[42]  Geng Xu,et al.  Suppression of TIM-1 predicates clinical efficacy of sublingual immunotherapy for allergic rhinitis in children. , 2013, International journal of pediatric otorhinolaryngology.

[43]  J. Bousquet,et al.  Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. , 2013, The Journal of allergy and clinical immunology.

[44]  Lei Cheng,et al.  Fast onset of action of sublingual immunotherapy in house dust mite‐induced allergic rhinitis: A multicenter, randomized, double‐blind, placebo‐controlled trial , 2013, The Laryngoscope.

[45]  W. Fokkens,et al.  Disease-Specific Quality-of-Life Questionnaires in Rhinitis and Rhinosinusitis: Review and Evaluation , 2013, Current Allergy and Asthma Reports.

[46]  Ya-mei Zhang,et al.  Prevalence and associated risk factors of allergic rhinitis in preschool children in Beijing , 2013, The Laryngoscope.

[47]  Lei Cheng,et al.  [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis]. , 2011, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[48]  Tian-ying Li,et al.  [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis]. , 2011, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[49]  Wen-jing Li,et al.  Effect of sublingual immunotherapy on level of cytokines in PBMCs of patients with allergic asthma , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[50]  S. Durham,et al.  Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. , 2011, The Journal of allergy and clinical immunology.

[51]  Jing Zhao,et al.  Self-reported prevalence of childhood allergic diseases in three cities of China: a multicenter study , 2010, BMC public health.

[52]  M. Blaiss,et al.  The Childhood Asthma Control Test: retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma. , 2010, The Journal of allergy and clinical immunology.

[53]  G. Pajno,et al.  Sublingual immunotherapy: adherence based on timing and monitoring control visits , 2010, Allergy.

[54]  P. Matricardi.  99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Controversial aspects of the ‘hygiene hypothesis’ , 2010, Clinical and experimental immunology.

[55]  W. Kong,et al.  [Compliance analysis of sublingual immunotherapy and countermeasures]. , 2010, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[56]  J. Li,et al.  A multicentre study assessing the prevalence of sensitizations in patients with asthma and/or rhinitis in China , 2009, Allergy.

[57]  Z-Y Zheng,et al.  Prevalence of allergic rhinitis in 3–6‐year‐old children in Wuhan of China , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[58]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[59]  Yan-Ping Chen,et al.  [Clinical evaluation for sublingual immunotherapy of allergic asthma and atopic rhinitis with Dermatophagoides Farinae Drops]. , 2007, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[60]  B. Bohle,et al.  Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. , 2007, The Journal of allergy and clinical immunology.

[61]  J Bousquet,et al.  Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce , 2007, Allergy.

[62]  L. Cox,et al.  Sublingual immunotherapy: a comprehensive review. , 2006, The Journal of allergy and clinical immunology.

[63]  G. Ciprandi,et al.  The safety of sublingual‐swallow immunotherapy: an analysis of published studies , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[64]  R. Amedee,et al.  Nasal Provocation Testing as an International Standard for Evaluation of Allergic and Nonallergic Rhinitis , 2005, The Laryngoscope.

[65]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[66]  B. Baldo.  Standardization of Allergens , 1983, Allergy.

[67]  L. Noon.  Prophylactic inoculation against hay fever. , 1911, International archives of allergy and applied immunology.

[68]  L. Cheng,et al.  Sublingual immunotherapy of house dust mite respiratory allergy in China. , 2019, Allergologia et immunopathologia.

[69]  N. Surgery.  [Chinese guidelines for diagnosis and treatment of allergic rhinitis]. , 2016, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[70]  D. Barber,et al.  Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. , 2014, The Journal of allergy and clinical immunology.

[71]  [Third nationwide survey of childhood asthma in urban areas of China]. , 2013, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[72]  Wen-jing Li 李文静,et al.  Effect of sublingual immunotherapy on level of cytokines in PBMCs of patients with allergic asthma , 2011, Journal of Huazhong University of Science and Technology [Medical Sciences].

[73]  J. Douglass,et al.  House dust mite sublingual immunotherapy - the role for TGF-beta and functional regulatory T cells , 2009 .

[74]  R. Beasley,et al.  The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.